Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes (Q35084516)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

pertussis vaccine

1 reference

based on heuristic

inferred from title

Peter van der Ley

11

object named as

Peter van der Ley

0 references

Daniela Flavia Hozbor

13

object named as

Daniela F Hozbor

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Daniela Bottero

2

object named as

Daniela Bottero

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

María Emilia Gaillard

1

object named as

María Emilia Gaillard

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Agustina Juliana Errea

3

object named as

Agustina Errea

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

María Eugenia Zurita

5

object named as

M Eugenia Zurita

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

7

object named as

Martin Rumbo

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Maximiliano Ormazábal

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Griselda Moreno

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Celina Castuma

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Erika Bartel

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dario Flores

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Peter van der Ley

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Arno van der Ark

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

4 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

931-937

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Development of a pertussis component vaccine in Japan

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Comparative genomics of prevaccination and modern Bordetella pertussis strains

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Duration of immunity against pertussis after natural infection or vaccination

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Release of outer membrane vesicles from Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Outer membrane vesicles as acellular vaccine against pertussis

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Multilocus sequence typing of Bordetella pertussis based on surface protein genes

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Recent developments in adjuvants for vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

based on heuristic

inferred from DOI database lookup

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2013.12.048

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.12.048

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35084516&oldid=1971822392"